It is now known that there are major differences in the systemic and c
ellular mechanisms that mediate hair loss in women versus men. The sev
erity or degree of hair loss in women with androgenetic alopecia is us
ually much less than in men. It is usually assumed that the hormonal b
asis for androgenetic alopecia in women is Me same as in men; that is,
the same target tissue-active androgens, testosterone and dihydrotest
osterone, are being produced systemically to aggravate scalp hair foll
icles, resulting in hair loss. This article reviews some of the latest
findings in androgenetic alopecia for both men and women, along with
new and old treatments and drugs, doses, and effectiveness. Research f
indings indicate that levels of androgen-metabolizing enzymes and rece
ptors differ in the scalps of women versus men, which may be important
in formulating more effective hair, growth treatments in the future.